Table 2 Clinical response according to... | American Society of Hematology

Table 2

Clinical response according to LEF1 expression (overall cohort)

Clinical outcome	LEF1 low	LEF1 high	P
Complete remission rate
CR/total, no. (%)*	173/199 (87)	57/68 (84)	.54
Refractory disease
Refractory/total, no. (%)†	16/189 (9)	4/61 (7)	.79
Relapse rate
Relapse/total, no. (%)‡	41/84 (49)	20/27 (74)	.03

Clinical outcome	LEF1 low	LEF1 high	P
Complete remission rate
CR/total, no. (%)*	173/199 (87)	57/68 (84)	.54
Refractory disease
Refractory/total, no. (%)†	16/189 (9)	4/61 (7)	.79
Relapse rate
Relapse/total, no. (%)‡	41/84 (49)	20/27 (74)	.03

N = 267. For 15 patients, no remission status was available.

N = 250. Seventeen patients who died during induction therapy were excluded.

N = 111. Patients who received SCT in CR1 were excluded for evaluation of the relapse rate.